Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization.
Identifieur interne : 000577 ( PubMed/Curation ); précédent : 000576; suivant : 000578Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization.
Auteurs : Frédéric Chamberland ; Tristan Maurina [France] ; Séverine Degano-Valmary [France] ; Thierry Spicarolen ; Loïc Chaigneau [France]Source :
- Rare tumors [ 2036-3605 ] ; 2016.
Abstract
Angiosarcomas are one of the rarest subtypes of sarcomas; those are malignant vascular tumors arising from vascular endothelial cells. Occurrence of intra-oral angiosarcoma is extremely rare (0.0077% of all cancers in Europe). We present here, to our knowledge, the first case of a 83-year-old man with gingival and both palatine tonsils localization of a grade-two angiosarcoma discovered after a two months history of a painful lesion followed by hematoma and spontaneous bleeding. Chemotherapy with paclitaxel and hemostatic radiotherapy were inefficient and he died seven months after the first symptoms. It is essential to use the vascular markers, such as CD34, CD31, ERG and FLI1, for a correct histological diagnosis, which remains difficult because it displays a wide range of morphological appearances and multiple patterns may be present in the same tumor. The main prognostic factors are chronic pre-existing lymphedema and tumor size greater than five centimeters. Malignancy grade and stage classification should be provided in all cases in which this is feasible because of predictive meaning. When possible, wide surgical resection with negative margins remains the cornerstone for the treatment of localized angiosarcomas, but despite the improvement of surgical techniques the prognosis is poor with more than half of patients died within the first year. Adjuvant radiotherapy is the standard treatment of high-grade (two and three), deep lesions, regardless of size, because it improved the local recurrence-free survival. For advanced disease, if possible, metastasectomy should be considered. The first-line chemotherapy with doxorubicin or paclitaxel should be discussed compared to best supportive care according to patient comorbidities and preference.
DOI: 10.4081/rt.2016.5907
PubMed: 27746875
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000577
Links to Exploration step
pubmed:27746875Curation
No country items
Frédéric Chamberland<affiliation><nlm:affiliation>Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Nord Franche-Comté , Belfort.</nlm:affiliation><wicri:noCountry code="subField">Belfort</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Nord Franche-Comté , Belfort.</nlm:affiliation><wicri:noCountry code="subField">Belfort</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization.</title><author><name sortKey="Chamberland, Frederic" sort="Chamberland, Frederic" uniqKey="Chamberland F" first="Frédéric" last="Chamberland">Frédéric Chamberland</name><affiliation><nlm:affiliation>Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Nord Franche-Comté , Belfort.</nlm:affiliation><wicri:noCountry code="subField">Belfort</wicri:noCountry></affiliation></author><author><name sortKey="Maurina, Tristan" sort="Maurina, Tristan" uniqKey="Maurina T" first="Tristan" last="Maurina">Tristan Maurina</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, University Hospital Center Jean Minjoz , Besançon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Oncology, University Hospital Center Jean Minjoz , Besançon</wicri:regionArea></affiliation></author><author><name sortKey="Degano Valmary, Severine" sort="Degano Valmary, Severine" uniqKey="Degano Valmary S" first="Séverine" last="Degano-Valmary">Séverine Degano-Valmary</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, University Hospital Center Jean Minjoz , Besançon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Pathology, University Hospital Center Jean Minjoz , Besançon</wicri:regionArea></affiliation></author><author><name sortKey="Spicarolen, Thierry" sort="Spicarolen, Thierry" uniqKey="Spicarolen T" first="Thierry" last="Spicarolen">Thierry Spicarolen</name><affiliation><nlm:affiliation>Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Nord Franche-Comté , Belfort.</nlm:affiliation><wicri:noCountry code="subField">Belfort</wicri:noCountry></affiliation></author><author><name sortKey="Chaigneau, Loic" sort="Chaigneau, Loic" uniqKey="Chaigneau L" first="Loïc" last="Chaigneau">Loïc Chaigneau</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, University Hospital Center Jean Minjoz , Besançon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Oncology, University Hospital Center Jean Minjoz , Besançon</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27746875</idno><idno type="pmid">27746875</idno><idno type="doi">10.4081/rt.2016.5907</idno><idno type="wicri:Area/PubMed/Corpus">000577</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000577</idno><idno type="wicri:Area/PubMed/Curation">000577</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000577</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization.</title><author><name sortKey="Chamberland, Frederic" sort="Chamberland, Frederic" uniqKey="Chamberland F" first="Frédéric" last="Chamberland">Frédéric Chamberland</name><affiliation><nlm:affiliation>Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Nord Franche-Comté , Belfort.</nlm:affiliation><wicri:noCountry code="subField">Belfort</wicri:noCountry></affiliation></author><author><name sortKey="Maurina, Tristan" sort="Maurina, Tristan" uniqKey="Maurina T" first="Tristan" last="Maurina">Tristan Maurina</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, University Hospital Center Jean Minjoz , Besançon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Oncology, University Hospital Center Jean Minjoz , Besançon</wicri:regionArea></affiliation></author><author><name sortKey="Degano Valmary, Severine" sort="Degano Valmary, Severine" uniqKey="Degano Valmary S" first="Séverine" last="Degano-Valmary">Séverine Degano-Valmary</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, University Hospital Center Jean Minjoz , Besançon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Pathology, University Hospital Center Jean Minjoz , Besançon</wicri:regionArea></affiliation></author><author><name sortKey="Spicarolen, Thierry" sort="Spicarolen, Thierry" uniqKey="Spicarolen T" first="Thierry" last="Spicarolen">Thierry Spicarolen</name><affiliation><nlm:affiliation>Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Nord Franche-Comté , Belfort.</nlm:affiliation><wicri:noCountry code="subField">Belfort</wicri:noCountry></affiliation></author><author><name sortKey="Chaigneau, Loic" sort="Chaigneau, Loic" uniqKey="Chaigneau L" first="Loïc" last="Chaigneau">Loïc Chaigneau</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, University Hospital Center Jean Minjoz , Besançon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Oncology, University Hospital Center Jean Minjoz , Besançon</wicri:regionArea></affiliation></author></analytic><series><title level="j">Rare tumors</title><idno type="ISSN">2036-3605</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Angiosarcomas are one of the rarest subtypes of sarcomas; those are malignant vascular tumors arising from vascular endothelial cells. Occurrence of intra-oral angiosarcoma is extremely rare (0.0077% of all cancers in Europe). We present here, to our knowledge, the first case of a 83-year-old man with gingival and both palatine tonsils localization of a grade-two angiosarcoma discovered after a two months history of a painful lesion followed by hematoma and spontaneous bleeding. Chemotherapy with paclitaxel and hemostatic radiotherapy were inefficient and he died seven months after the first symptoms. It is essential to use the vascular markers, such as CD34, CD31, ERG and FLI1, for a correct histological diagnosis, which remains difficult because it displays a wide range of morphological appearances and multiple patterns may be present in the same tumor. The main prognostic factors are chronic pre-existing lymphedema and tumor size greater than five centimeters. Malignancy grade and stage classification should be provided in all cases in which this is feasible because of predictive meaning. When possible, wide surgical resection with negative margins remains the cornerstone for the treatment of localized angiosarcomas, but despite the improvement of surgical techniques the prognosis is poor with more than half of patients died within the first year. Adjuvant radiotherapy is the standard treatment of high-grade (two and three), deep lesions, regardless of size, because it improved the local recurrence-free survival. For advanced disease, if possible, metastasectomy should be considered. The first-line chemotherapy with doxorubicin or paclitaxel should be discussed compared to best supportive care according to patient comorbidities and preference.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27746875</PMID><DateCreated><Year>2016</Year><Month>10</Month><Day>17</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2036-3605</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>Rare tumors</Title><ISOAbbreviation>Rare Tumors</ISOAbbreviation></Journal><ArticleTitle>Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization.</ArticleTitle><Pagination><MedlinePgn>5907</MedlinePgn></Pagination><Abstract><AbstractText>Angiosarcomas are one of the rarest subtypes of sarcomas; those are malignant vascular tumors arising from vascular endothelial cells. Occurrence of intra-oral angiosarcoma is extremely rare (0.0077% of all cancers in Europe). We present here, to our knowledge, the first case of a 83-year-old man with gingival and both palatine tonsils localization of a grade-two angiosarcoma discovered after a two months history of a painful lesion followed by hematoma and spontaneous bleeding. Chemotherapy with paclitaxel and hemostatic radiotherapy were inefficient and he died seven months after the first symptoms. It is essential to use the vascular markers, such as CD34, CD31, ERG and FLI1, for a correct histological diagnosis, which remains difficult because it displays a wide range of morphological appearances and multiple patterns may be present in the same tumor. The main prognostic factors are chronic pre-existing lymphedema and tumor size greater than five centimeters. Malignancy grade and stage classification should be provided in all cases in which this is feasible because of predictive meaning. When possible, wide surgical resection with negative margins remains the cornerstone for the treatment of localized angiosarcomas, but despite the improvement of surgical techniques the prognosis is poor with more than half of patients died within the first year. Adjuvant radiotherapy is the standard treatment of high-grade (two and three), deep lesions, regardless of size, because it improved the local recurrence-free survival. For advanced disease, if possible, metastasectomy should be considered. The first-line chemotherapy with doxorubicin or paclitaxel should be discussed compared to best supportive care according to patient comorbidities and preference.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chamberland</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Nord Franche-Comté , Belfort.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurina</LastName><ForeName>Tristan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Oncology, University Hospital Center Jean Minjoz , Besançon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degano-Valmary</LastName><ForeName>Séverine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, University Hospital Center Jean Minjoz , Besançon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spicarolen</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Nord Franche-Comté , Belfort.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaigneau</LastName><ForeName>Loïc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Oncology, University Hospital Center Jean Minjoz , Besançon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Rare Tumors</MedlineTA><NlmUniqueID>101526926</NlmUniqueID><ISSNLinking>2036-3605</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Jul 1;27(19):3133-40</RefSource><PMID Version="1">19451436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Oral Maxillofac Surg. 1991 Feb;29(1):38-41</RefSource><PMID Version="1">2004075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1987 Aug;13(8):1127-33</RefSource><PMID Version="1">3610701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 1970 Oct;120(4):501-4</RefSource><PMID Version="1">5528317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oral Maxillofac Surg. 1988 Jun;46(6):496-8</RefSource><PMID Version="1">3164055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer J. 2005 May-Jun;11(3):241-7</RefSource><PMID Version="1">16053668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1981 Oct 15;48(8):1907-21</RefSource><PMID Version="1">7197190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oral Surg. 1977 Jul;35(7):590-4</RefSource><PMID Version="1">267178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2011 Nov;47(17):2493-511</RefSource><PMID Version="1">22033323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2007 Dec;18(12):2030-6</RefSource><PMID Version="1">17974557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oral Surg. 1970 Dec;28(12):913-7</RefSource><PMID Version="1">5273823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2012;17(2):260-6</RefSource><PMID Version="1">22285963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2010 Jan;176(1):34-9</RefSource><PMID Version="1">20008140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mod Pathol. 1994 Jan;7(1):82-90</RefSource><PMID Version="1">7512718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oral Oncol. 1998 Jul;34(4):292-6</RefSource><PMID Version="1">9813725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mod Pathol. 2003 Mar;16(3):263-71</RefSource><PMID Version="1">12640107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg Pathol. 1998 Jun;22(6):683-97</RefSource><PMID Version="1">9630175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg Pathol. 2011 Mar;35(3):432-41</RefSource><PMID Version="1">21317715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Dermatopathol. 1986 Oct;8(5):430-5</RefSource><PMID Version="1">3096160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Chromosomes Cancer. 2011 Jan;50(1):25-33</RefSource><PMID Version="1">20949568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mod Pathol. 2012 Jan;25(1):75-85</RefSource><PMID Version="1">21909081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Feb;23(2):517-23</RefSource><PMID Version="1">21566149</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oral Pathol Med. 1999 Feb;28(2):92-5</RefSource><PMID Version="1">9950257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Pathol. 2012 Jul;43(7):1142-7</RefSource><PMID Version="1">22406364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Otolaryngol. 1950 Nov-Dec;67(11-12):816-22</RefSource><PMID Version="1">14811166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg Pathol. 2001 Aug;25(8):1061-6</RefSource><PMID Version="1">11474291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2008 Nov;44(16):2433-6</RefSource><PMID Version="1">18771914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2005 Jul 15;104(2):361-6</RefSource><PMID Version="1">15948172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ear Nose Throat J. 2011 Mar;90(3):116-20</RefSource><PMID Version="1">21412741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oral Maxillofac Surg. 2010 Jun;39(6):568-72</RefSource><PMID Version="1">20413272</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 May 10;104(10):1544-50</RefSource><PMID Version="1">21505457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2013 Jan;49(2):369-76</RefSource><PMID Version="1">22967726</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(8):e20294</RefSource><PMID Version="1">21826194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1979 May;43(5):1664-71</RefSource><PMID Version="1">571756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Cytol. 1997 May-Jun;41(3):839-44</RefSource><PMID Version="1">9167711</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Head Face Med. 2008 Jul 31;4:17</RefSource><PMID Version="1">18671846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Nov 10;26(32):5269-74</RefSource><PMID Version="1">18809609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2012 Jul 1;118(13):3330-6</RefSource><PMID Version="1">22045619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oral Oncol. 2002 Dec;38(8):757-62</RefSource><PMID Version="1">12570054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2000 Mar;26(2):145-8</RefSource><PMID Version="1">10744932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Oral Investig. 2004 Jun;8(2):52-5</RefSource><PMID Version="1">15281217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fukushima J Med Sci. 2005 Dec;51(2):77-85</RefSource><PMID Version="1">16555628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1999 Nov 15;86(10):2034-7</RefSource><PMID Version="1">10570428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cutan Pathol. 1995 Jun;22(3):215-22</RefSource><PMID Version="1">7593814</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiosarcoma</Keyword><Keyword MajorTopicYN="N">gingiva</Keyword><Keyword MajorTopicYN="N">head and neck</Keyword><Keyword MajorTopicYN="N">palatine tonsil</Keyword></KeywordList><CoiStatement>the authors declare no potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>04</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27746875</ArticleId><ArticleId IdType="doi">10.4081/rt.2016.5907</ArticleId><ArticleId IdType="pmc">PMC5064291</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000577 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000577 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:27746875
|texte= Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:27746875" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |